Neuropsychopharmacology

And a better understanding of this can lead to new treatments.

Joshua Gray is an associate professor in the Department of Psychology at Uniformed Services University and one of the authors of a new study in the journal Neuropsychopharmacology.

The views expressed are those of Dr.

Gray and don't represent the Department of War.

Does that go down over time? So it's another way of building an evidence base around the most promising targets and seeing which are worth going into clinical trials and which are not.

And so also the which are not is important, too, because I can save a lot of resources and allocate those to more promising directions.

This is the podcast for the journal Neuropsychopharmacology.

To read the article discussed in the podcast, go to www.nature.com slash NPP.